Ferris Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Ferris Capital’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20	Closed	-$2K	–	681
2018 Q1	$2K	Buy	+20	New	+$1.55K	﹤0.01%	630

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ferris Capital's AGIO Position: Q2 2018 in Review

Ferris Capital sold out of Agios Pharmaceuticals (AGIO) in Q2 2018, closing a stake of 20 shares — an estimated $2K sold.

Ferris Capital first reported a position in AGIO in Q1 2018 and held it in 1 quarter. The position peaked at $2K in Q1 2018. 217 funds tracked by Wall St. Rank hold AGIO as of Q2 2018.

Ferris Capital reported no remaining Agios Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
Ferris Capital sold 20 Agios Pharmaceuticals shares in Q2 2018, an estimated $2K.
Ferris Capital first reported a position in Agios Pharmaceuticals in Q1 2018 and held it in 1 quarter.
Ferris Capital's Agios Pharmaceuticals position peaked at $2K in Q1 2018.
217 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2018.

Based on Ferris Capital's 13F filing for Q2 2018, filed 10 Aug 2018.